Molecular analysis of key factors involved in the mechanism of invasion in gliomas
胶质瘤侵袭机制关键因素的分子分析
基本信息
- 批准号:09671448
- 负责人:
- 金额:$ 2.05万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The malignant behavior of glioma is characterized by its invasiveness and its biological mechanism is of significant interest among scientists, Key factors contributing to its biology is yet to be determined. Hepatocyte growth factor (HGF) which has various physiological functions, and its receptor c-Met are thought to be determinant in the pathological processes of various malignancies. Concominant expression of HGF and c-met genes has been reported in glioma cell lines but little is known about the characteristics in glioma tissue. We made an analysis to elucidate the function of c-Met in glioma tissues which are concluded that 1) cultured astrocytes express c-Met protein and, 2) various neurotropic factors elevate the expression of NGF, 3) expression of c-Met protein interrelates with the recurrence of low-grade astrocytomas, and interrelation with the mechanism of invasion of glioma and not the malignant progression.Cell adhesion molecules are also among the key factors of the malignant potential of brain tumors. Evidence from usage of glioma cell lines has shown correlation of neural cell adhesion molecule (NCAM) with the migratory and invasive potential nature. He studied the expression of NCAM in astrocytic tumors which elucidated that each NCAM isoform decreased its proportion to the progression of the histological malignancy. In other words, reduced NCAM expression might result in development of biological malignancy. We also ascertained the expression and the relation of Musashi expression which is known as a key factor in maturation of the neural stem cell.
胶质瘤的恶性行为以其侵袭性为特征,其生物学机制一直是科学家们关注的焦点,其生物学机制的关键因素尚未确定。肝细胞生长因子(Hepatocyte growth factor,HGF)具有多种生理功能,其受体c-Met被认为在多种恶性肿瘤的病理过程中起决定性作用。HGF和c-met基因在胶质瘤细胞系中同时表达已有报道,但在胶质瘤组织中的表达特点尚不清楚。我们对c-Met在脑胶质瘤组织中的作用进行了分析,得出以下结论:1)培养的星形胶质细胞表达c-Met蛋白,2)各种神经营养因子提高了NGF的表达,3)c-Met蛋白的表达与低级别星形胶质细胞瘤的复发相关,与胶质瘤的侵袭机制有关,而与其恶性进展无关,细胞粘附分子也是胶质瘤恶性潜能的关键因素之一。脑瘤神经胶质瘤细胞系的使用证据表明,神经细胞粘附分子(NCAM)与迁移和侵袭潜力的性质。他研究了NCAM在星形细胞肿瘤中的表达,阐明了每种NCAM亚型随着组织学恶性肿瘤的进展而降低其比例。换句话说,NCAM表达减少可能导致生物恶性肿瘤的发展。我们还确定了神经干细胞成熟的关键因子Musashi的表达及其相互关系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yoshida K,Toya S.: "Neurotrophic activity in cytokine-activatedastrocytes"Keio J Med. 46(2). 55-60 (1997)
Yoshida K,Toya S.:“细胞因子激活的星形胶质细胞中的神经营养活性”Keio J Med。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hirose Y,Yoshida K,et al.: "Immunohistodiemical examination of c-Met protein expression in astrooylic tumors." Acta・Nueropathologica. 95. 345-351 (1998)
Hirose Y, Yoshida K, et al.:“星状肿瘤中 c-Met 蛋白表达的免疫组织学检查。Acta·Neropathologica”95. 345-351 (1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y.Hirose,M.Kojima,M.Sagoh,T.Hayashi,H.Murakami,K.Shimazaki,K.Yoshida,T.Kawase: "Clinical importance of c-Met protein expression in high grade astrocytic tumors"Neurol.Med.Chir. 38(12). 851-59 (1998)
Y.Hirose、M.Kojima、M.Sagoh、T.Hayashi、H.Murakami、K.Shimazaki、K.Yoshida、T.Kawase:“c-Met 蛋白表达在高级星形细胞肿瘤中的临床重要性”Neurol.Med
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M.Toda,Y.Iizuka,W.Yu,T.Imai,E.Ikeda,K.Yoshida,T.Kawase,Y.Kawakami,H.Okano,K.Uyemura: "Expression of the neural RNA- binding protein Musashi1 in human gliomas"Glia. (In press). (2001)
M.Toda,Y.Iizuka,W.Yu,T.Imai,E.Ikeda,K.Yoshida,T.Kawase,Y.Kawakami,H.Okano,K.Uyemura:“神经 RNA 结合蛋白 Musashi1 的表达
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
吉田一成: "神経線維腫"別冊日本臨床領域別症候群シリーズNo.28神経症候群III. 128-129 (2000)
Kazunari Yoshida:“神经纤维瘤”特别版日本临床领域综合症系列第 28 期神经综合症 III 128-129 (2000)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YOSHIDA Kazunari其他文献
YOSHIDA Kazunari的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YOSHIDA Kazunari', 18)}}的其他基金
Mass-production technology of guide wire, stent and implant dentistry with human boby-friendly
人体友好型导丝、支架、种植牙批量生产技术
- 批准号:
23560879 - 财政年份:2011
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Towards molecular-guided personalized therapy of gliomas -clarifyingthe indication of neoadjuvant approach for gliomas-
走向分子引导的神经胶质瘤个性化治疗 - 阐明神经胶质瘤新辅助方法的适应症 -
- 批准号:
22591619 - 财政年份:2010
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proteomics approach to discover biomarker for kidney transplant rejection
蛋白质组学方法发现肾移植排斥反应的生物标志物
- 批准号:
19591885 - 财政年份:2007
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Manufacturing of Microparts for medical and Dental Use by Plastic working
通过塑料加工制造医疗和牙科用微型零件
- 批准号:
15360393 - 财政年份:2003
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Fabrication Process for Ni-Ti Shape-Memory-Alloy Fine Tubes Used in Medical Tests
医学检验用镍钛形状记忆合金细管的制造工艺
- 批准号:
10650715 - 财政年份:1998
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Neurotrophic Effects of Cytokine-activated Astrocytes.-Basic research for Elucidation of Interaction between Neuron and Glia, and Restoration of Damaged Neuronal Function-
细胞因子激活的星形胶质细胞的神经营养作用。-阐明神经元和神经胶质细胞之间的相互作用以及受损神经元功能恢复的基础研究-
- 批准号:
08671615 - 财政年份:1996
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
NEUROTROPHIC ACTIVITY OF CYTOKINE-ACTIVATED ASTROCYTES
细胞因子激活星形胶质细胞的神经营养活性
- 批准号:
05671183 - 财政年份:1993
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
脊髓新鉴定SNAPR神经元相关环路介导SCS电刺激抑制恶性瘙痒
- 批准号:82371478
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
- 批准号:82373145
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
"胚胎/生殖细胞发育特性激活”促进“神经胶质瘤恶变”的机制及其临床价值研究
- 批准号:82372327
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
IL-6自主分泌介导的B细胞来源淋巴造血系统肿瘤耐药的相关机制研究
- 批准号:81172109
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
microRNA-21靶向的肿瘤反义基因显像研究
- 批准号:81101065
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
Thalidomide增强temozolomide对恶性胶质瘤治疗作用潜在机理的研究
- 批准号:30772228
- 批准年份:2007
- 资助金额:30.0 万元
- 项目类别:面上项目
携带CD-UPRT双功能基因的内皮祖细胞载体靶向治疗恶性胶质瘤的实验研究
- 批准号:30571904
- 批准年份:2005
- 资助金额:25.0 万元
- 项目类别:面上项目
相似海外基金
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:
10752555 - 财政年份:2024
- 资助金额:
$ 2.05万 - 项目类别:
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
- 批准号:
10481965 - 财政年份:2024
- 资助金额:
$ 2.05万 - 项目类别:
Designing Rational Combinations to Improve CAR T Cell Therapy for Prostate Cancer
设计合理的组合以改善前列腺癌的 CAR T 细胞疗法
- 批准号:
10752046 - 财政年份:2024
- 资助金额:
$ 2.05万 - 项目类别:
Greatwall in replication stress/DNA damage responses and oral cancer resistance
长城在复制应激/DNA损伤反应和口腔癌抵抗中的作用
- 批准号:
10991546 - 财政年份:2024
- 资助金额:
$ 2.05万 - 项目类别:
DNA repair pathway coordination during damage processing
损伤处理过程中 DNA 修复途径的协调
- 批准号:
10748479 - 财政年份:2024
- 资助金额:
$ 2.05万 - 项目类别:
Glut1+ cancer associated fibroblasts enforce a metabolic barrier to tumor T cell infiltration
Glut1癌症相关成纤维细胞增强了肿瘤T细胞浸润的代谢屏障
- 批准号:
10752508 - 财政年份:2024
- 资助金额:
$ 2.05万 - 项目类别:
Epigenomic Methods to Improve Personalised Treatment in Patients with Lung Cancer and Malignant Pleural Effusion.
表观基因组方法改善肺癌和恶性胸腔积液患者的个体化治疗。
- 批准号:
MR/X030938/1 - 财政年份:2024
- 资助金额:
$ 2.05万 - 项目类别:
Research Grant
Investigating FGF Signaling Dynamics in migrating cells
研究迁移细胞中的 FGF 信号动力学
- 批准号:
10679898 - 财政年份:2024
- 资助金额:
$ 2.05万 - 项目类别:
Anti-Complement Immunotherapy for Pancreatic Cancer
胰腺癌的抗补体免疫治疗
- 批准号:
10751872 - 财政年份:2024
- 资助金额:
$ 2.05万 - 项目类别:
GLIOMATCH: The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomics
GLIOMATCH:恶性胶质瘤免疫肿瘤学媒人:利用空间分辨的放射多组学实现数据驱动的精准医学
- 批准号:
10113516 - 财政年份:2024
- 资助金额:
$ 2.05万 - 项目类别:
EU-Funded














{{item.name}}会员




